Tumor Treating Fields (TTFields) Concomitant with Immune Checkpoint Inhibitors Are Therapeutically Effective in Non-Small Cell Lung Cancer (NSCLC) In Vivo Model.

Barsheshet, Yiftah; Voloshin, Tali; Brant, Boris; Cohen, Gadi; Koren, Lilach; Blatt, Roni; Cahal, Shay; Haj Khalil, Tharwat; Zemer Tov, Efrat; Paz, Rom; Klein-Goldberg, Anat; Tempel-Brami, Catherine; Jacobovitch, Sara; Volodin, Alexandra; Kan, Tal; Koltun, Bella; David, Cfir; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram

Barsheshet, Yiftah; Voloshin, Tali; Brant, Boris; Cohen, Gadi; Koren, Lilach; Blatt, Roni; Cahal, Shay; Haj Khalil, Tharwat; Zemer Tov, Efrat; Paz, Rom; Klein-Goldberg, Anat; Tempel-Brami, Catherine; Jacobovitch, Sara; Volodin, Alexandra; Kan, Tal; Koltun, Bella; David, Cfir; Haber, Adi; Giladi, Moshe; Weinberg, Uri; Palti, Yoram.

Afiliación

Barsheshet Y; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Voloshin T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Brant B; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Cohen G; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Koren L; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Blatt R; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Cahal S; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Haj Khalil T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Zemer Tov E; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Paz R; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Klein-Goldberg A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Tempel-Brami C; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Jacobovitch S; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Volodin A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Kan T; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Koltun B; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
David C; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Haber A; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Giladi M; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Weinberg U; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.
Palti Y; Novocure Ltd., Topaz Building, MATAM Center, Haifa 31905, Israel.

Int J Mol Sci ; 23(22)2022 Nov 15.

Article en En | MEDLINE | ID: mdl-36430552

Asunto(s)

Carcinoma de Pulmón de Células no Pequeñas; Neoplasias Pulmonares; Ratones; Animales; Carcinoma de Pulmón de Células no Pequeñas/patología; Inhibidores de Puntos de Control Inmunológico/farmacología; Inhibidores de Puntos de Control Inmunológico/uso terapéutico; Neoplasias Pulmonares/tratamiento farmacológico; Supervivencia Celular/fisiología; Huso Acromático

Palabras clave

Tumor Treating Fields (TTFields); anti-CTLA-4 therapy; anti-PD-1 therapy; anti-PD-L1 therapy; immunogenic cell death; non-small cell lung cancer (NSCLC)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google